Infectious Disease Archives | Page 2 of 7 | Certara

Blog

Applying decision analysis to drug development for COVID-19 & future pandemics

This blog discusses how decision analysis approaches can help drug developers to better decisions under…

CertaraApril 30, 2020

Publication

Use of Modeling and Simulations to Determine Raltegravir Dosing in Neonates: A Model for Safely and Efficiently Determining Appropriate Neonatal Dosing Regimens: IMPAACT P1110

CertaraJanuary 17, 2020

Publication

Maternal-Neonatal Raltegravir Population Pharmacokinetics Modeling: Implications for Initial Neonatal Dosing

Maternal-Neonatal Raltegravir Population Pharmacokinetics Modeling: Implications for Initial Neonatal Dosing

CertaraJanuary 17, 2020

Poster

Population Pharmacokinetics of Piperacillin-Tazobactam Extended Infusions in Paediatric Population

CertaraJune 24, 2019

Poster

Pharmacodynamics of rituximab on B cells in paediatric post-HSCT patients with EBV

CertaraJune 24, 2019

Publication

A Population Pharmacokinetic Model for a Solid Oral Tablet Formulation of Posaconazole

CertaraJuly 1, 2018

Publication

Pharmacokinetics of Praziquantel in Schistosoma Mansoni- and Schistosoma Haematobium-infected School- and Preschool-aged Children

CertaraJune 4, 2018

Publication

Population Pharmacokinetics of Intravenous Linezolid in Premature Infants

CertaraApril 9, 2018

Publication

Quantitative Analysis of Gentamicin Exposure in Neonates and Infants Calls into Question Its Current Dosing Recommendations

CertaraApril 1, 2018

Publication

Population Pharmacokinetics of Teicoplanin in Hospitalized Elderly Patients Using Cystatin C as an Indicator of Renal Function

CertaraApril 1, 2018

© 2026 Certara. All Rights Reserved. | Legal | Privacy policy